文献速递血液净化与透析

不同国家腹膜透析治疗时间的差异:来自腹膜透析结局与实践模式研究的结果

Variation in Peritoneal Dialysis Time on Therapy by Country: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study.
PubMed 文献 · Clin J Am Soc Nephrol · 2022-01-01

该多国观察性腹膜透析结局与实践模式研究(PDOPPS)纳入2014至2017年6国218家中心7121例患者,计算5年内从腹膜透析起始至转血液透析、死亡或肾移植的累积发生率,并调整患者及中心因素的风险比。结果显示中位腹膜透析时间从英国1.7年到日本3.2年不等,肾移植率高的国家中位时间倾向更短;感染是转血液透析的首要原因,精神疾病史或体重指数升高者转血液透析风险更高;中心层面每周总Kt/V≥1.7的患者比例与死亡或转血液透析无关。

要点

  • 中位腹膜透析时间范围1.7年(英国)至3.2年(日本)。
  • 肾移植率较高的PDOPPS国家中位腹膜透析时间倾向更短。
  • 感染是转血液透析的首要原因,精神疾病史或体重指数升高者转血液透析风险更高。

核心结论

  • PDOPPS中肾移植率较高的国家中位腹膜透析时间倾向更短。
  • 识别感染为转血液透析首要原因及与转血液透析风险相关的患者和中心因素,可促进减少此类事件的干预。

研究设计与样本

  • 多国观察性腹膜透析结局与实践模式研究(PDOPPS),2014至2017年。
  • 随机选取6国(澳大利亚/新西兰、加拿大、日本、泰国、英国、美国)218家腹膜透析中心,共7121例患者。
  • 计算5年内从腹膜透析起始至转血液透析、死亡或肾移植的累积发生率,并调整患者和中心因素与死亡及转血液透析的风险比。

主要发现

  • 中位腹膜透析时间范围1.7年(四分位距0.8-2.9;英国)至3.2年(四分位距1.5-6.0;日本)。
  • 3年肾移植率范围32%(英国)至2%(日本和泰国),肾移植率较低者中位腹膜透析时间更长。
  • 调整后转血液透析风险在泰国最低,但泰国和美国死亡风险高于多数国家。
  • 感染是转血液透析的首要原因,有精神疾病史或体重指数升高的患者转血液透析风险更高。
  • 中心层面每周总Kt/V≥1.7的患者比例与死亡或转血液透析无关。

关键数值与推荐

  • 中位腹膜透析时间1.7年(四分位距0.8-2.9;英国)至3.2年(四分位距1.5-6.0;日本)。
  • 3年肾移植率32%(英国)至2%(日本和泰国)。
  • 中心层面每周总Kt/V≥1.7的患者比例与死亡或转血液透析无关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Quantifying contemporary peritoneal dialysis time on therapy is important for patients and providers. We describe time on peritoneal dialysis in the context of outcomes of hemodialysis transfer, death, and kidney transplantation on the basis of the multinational, observational Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) from 2014 to 2017. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Among 218 randomly selected peritoneal dialysis facilities (7121 patients) in the PDOPPS from Australia/New Zealand, Canada, Japan, Thailand, the United Kingdom, and the United States, we calculated the cumulative incidence from peritoneal dialysis start to hemodialysis transfer, death, or kidney transplantation over 5 years and adjusted hazard ratios for patient and facility factors associated with death and hemodialysis transfer. RESULTS: Median time on peritoneal dialysis ranged from 1.7 (interquartile range, 0.8-2.9; the United Kingdom) to 3.2 (interquartile range, 1.5-6.0; Japan) years and was longer with lower kidney transplantation rates (range: 32% [the United Kingdom] to 2% [Japan and Thailand] over 3 years). Adjusted hemodialysis transfer risk was lowest in Thailand, but death risk was higher in Thailand and the United States compared with most countries. Infection was the leading cause of hemodialysis transfer, with higher hemodialysis transfer risks seen in patients having psychiatric disorder history or elevated body mass index. The proportion of patients with total weekly Kt/V ≥1.7 at a facility was not associated with death or hemodialysis transfer. CONCLUSIONS: Countries in the PDOPPS with higher rates of kidney transplantation tended to have shorter median times on peritoneal dialysis. Identification of infection as a leading cause of hemodialysis transfer and patient and facility factors associated with the risk of hemodialysis transfer can facilitate interventions to reduce these events. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2022_05_31_CJN16341221.mp3.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Lambie M, Zhao J, McCullough K, et al. Variation in Peritoneal Dialysis Time on Therapy by Country: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol. 2022. PMID: 35641246. doi:10.2215/CJN.16341221

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。